BSECompany Update19 Oct 2026 · 19 Oct 2026, 12:54 pm
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 regarding non approval of proposed preferential issue of convertible warrants and request for closure of application for in-principle approval
Choksi Laboratories Ltd · 526546
✦ AI SummaryFundraise
Choksi Laboratories Ltd has informed that the proposed preferential issue of convertible warrants was not approved by shareholders and will not be proceeded with.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk2/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Choksi Laboratories Ltd - 526546 - Announcement under Regulation 30 (LODR)-Preferential Issue
Attachments (1)
📄pdf
Download →
0038a0c9-47da-4c58-905a-8be6572aa0e9.pdf
View document text
Corporate Office & Central Laboratory:
Survey No.9/1, Near Tulsiyana Industrial Park,
Gram Kumedi-453555 (MP) INDIA
Tel: +91 0731-3501112
Email: compliance_officer@choksilab.in
Website: www.choksilab.in
CIN: L85195MP1993PLC007471
To, Date: 19th October, 2026
The General Manager
BSE Limited
Corporate Relationship Department
P. J. Towers, Dalal Street,
Mumbai – 400001
Ref: Scrip Code: 526546, ISIN: INE493D01013
Subject: Intimation under Regulation 30 of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015, regarding non-approval of the proposed
preferential issue of convertible warrants and request for closure of application for
in-principle approval
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, we wish to inform you that the proposal for issuance of convertible
warrants on a preferential basis, as placed before the shareholders of Choksi Laboratories
Limited (“the Company”) at the Extra-Ordinary General Meeting held on Saturday, October
17, 2026, has not been approved by the shareholders of the Company.
Consequently, the proposed preferential issue of convertible warrants will not be proceeded
with, and the Company shall not take any further steps in relation to the said proposal.
It is further informed that the Promoters and the proposed allottees, in the proposed
preferential issue of convertible warrants have abstained from voting on the said resolution at
the EGM.
In view of the above, we request BSE Limited to kindly close the application for in-
principle approval submitted by the Company in connection with the aforesaid proposed
preferential issue of convertible warrants.
We request you to take the above information on record and do the needful.
Thanking you,
Yours faithfully,
For CHOKSI LABORATORIES LIMITED
PRAKHAR DUBEY
Company Secretary &
Compliance Officer
M. No.: F14327